HuagongsheHuagongshe Chemistry Print Report · For research reference only
6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazole → HCID 178454010, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazole | HCID 46738006 | — |
| Reactant | HCID 178526093 | HCID 178526093 | — |
| Product | HCID 178454010 | HCID 178454010 | 172.4% |
Reaction Steps
Following general procedure D, tert-butyl [trans-4-(6-bromo-3-(cyclopropanecarbonyl)quinolin-4-ylamino]cyclohexylcarbamate (49 mg, 0.100 mmol) was reacted with 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole (49 mg, 0.200 mmol) to afford the desired product (45.3 mg, 86%) as an off-white solid: ESI MS m/z 526 [C31H35N5O3+H]+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09120749B2 |
| Source dataset | uspto-grants-2015_09 |
| ORD ID | ord-fd7b653f5e2340fea1c628af767d3e67 |
| Source note | uspto-grants-2015_09 |